<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02110251</url>
  </required_header>
  <id_info>
    <org_study_id>PEARL study</org_study_id>
    <nct_id>NCT02110251</nct_id>
  </id_info>
  <brief_title>Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease</brief_title>
  <acronym>PEARL</acronym>
  <official_title>Exercise Therapy With Risk Factor Management and Life Style Coaching After Vascular Intervention for Patients With Peripheral Arterial Disease With Critical Limb Ischemia or Tissue Loss. A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with peripheral arterial disease with symptoms of critical ischemia or reduced
      tissue loss have a very high mortality and morbidity rate. So far, treatment strategies
      focused on the preservation of life and limb by an open surgical or endovascular
      revascularization, together with cardiovascular risk management and pain relief. Important
      modifiable factors related to mortality and morbidity are not covered in the current national
      and international guidelines. This study investigates the effects on mobility, mortality and
      quality of life with supplementation of the standard treatment of critical limb ischemia with
      supervised exercise therapy. Also a reduction of cardiovascular risk by intensive risk factor
      management and lifestyle coaching will be taken in to account. The supervised exercise
      therapy will take place under the supervision of a trained physiotherapist.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mobility</measure>
    <time_frame>2 years</time_frame>
    <description>Pain free walking distance WIQ ALDS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>2 years</time_frame>
    <description>RAND SF 36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Peripheral Arterial Disease, Rutherford Stage 4 and 5 With the Possibility to Improve Vascularization.</condition>
  <arm_group>
    <arm_group_label>Supervised exercise therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adequacy of initial therapy, Investigation degree of confusion and dementia, Preoperative preparation, Life-style coaching, Supervised Exercise therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Walking advice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care and a oral walking advice.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Supervised Exercise Therapy</intervention_name>
    <arm_group_label>Supervised exercise therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with peripheral arterial disease Rutherford stage 4 and 5, where it is
             possible to improve the vascularization of the affected leg with the help of an
             endovascular and / or open surgical vascular intervention.

          -  Patients with both legs are affected, but the most severe leg does not exceed stage 5.

        Exclusion Criteria:

          -  Severe cardiopulmonary comorbidity (NYHA 4) and previous amputations of lower leg or
             thigh.

          -  Patients with limited amputation of the toes can participate.

          -  Insufficient understanding of the Dutch language.

          -  No physiotherapy insurance.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joep Teijink, prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catharina Ziekenhuis Eindhoven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edith Willigendael</last_name>
    <phone>0032 72-5482432</phone>
    <email>E.M.Willigendael@mca.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Regine van Grinsven, MSc</last_name>
      <phone>0031 40 2396349</phone>
      <email>regine.v.grinsven@catharinaziekenhuis.nl</email>
    </contact>
    <contact_backup>
      <last_name>Nicole Verhofstad, Dr</last_name>
      <phone>0031 40 2396349</phone>
    </contact_backup>
    <investigator>
      <last_name>Joep Teijink</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Bakker, MD</last_name>
      <phone>0032 72 548 4444</phone>
      <email>N.Bakker2@mca.nl</email>
    </contact>
    <investigator>
      <last_name>Edith Willigendael, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2014</study_first_submitted>
  <study_first_submitted_qc>April 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2014</study_first_posted>
  <last_update_submitted>April 3, 2015</last_update_submitted>
  <last_update_submitted_qc>April 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catharina Ziekenhuis Eindhoven</investigator_affiliation>
    <investigator_full_name>Joep Teijink</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

